Key result
Elevated galectin-3 in comorbid diabetes and hypertension correlates with higher LV mass and NT-proBNP.
Observational (n=189)
Answers are grounded in this paper and cite their sources.
BACKGROUND: Galectin-3 is a protein widely distributed in the heart, brain and blood vessels, and has a regulatory role in inflammation, immunology and cancer. Many studies demonstrated that the increased level of galectin-3 is associated with progressive fibrosis and stiffening of the myocardium. The aim of this study was to investigate the role of galectin-3 in patients with type 2 diabetes (T2D) and/or arterial hypertension (HT). METHODS: Study population included 189 patients, with no coronary artery disease, divided into three groups: group 1 (T2D), group 2 (T2D+HT), and group 3 (HT). All subjects underwent routine laboratory tests, as well as specific biomarkers assessment [galectin-3, glycosylated hemoglobin (HbA1c), N- terminal fragment B-type natriuretic peptide (NT-proBNP)]. Cardiological evaluation included physical examination, transthoracic tissue Doppler echocardiography and stress echocardiography. RESULTS: The results of this study demonstrated significantly increased levels of galectin-3, blood glucose, and HbA1c in group 2. Also, echocardiographicaly, left ventricular (LV) diameters and IVS thickness were increased in this group of patients. Furthermore, in the same cohort a positive correlation between galectin-3 and NT-pro BNP, and galectin-3 and LV mass were demonstrated. In addition, a negative correlation between galectin-3 and LV end-diastolic diameter was revealed. CONCLUSIONS: This study revealed that levels of galectin-3 were higher in patients with both T2D and HT, and correlated with LV mass, indicating the potential role of this biomarker for early detection of myocardial structural and functional alterations.
No takes yet. Share an insight, caveat, or question.
Seferović et al. (2014) conducted an observational in Type 2 diabetes and/or arterial hypertension (n=189). Type 2 diabetes combined with arterial hypertension (Galectin-3 evaluation) vs. Type 2 diabetes alone or arterial hypertension alone was evaluated on Galectin-3 levels and echocardiographic structural myocardial parameters (LV mass, LV diameters, IVS thickness). Galectin-3 levels were significantly higher in patients with both T2D and HT (N=189) and positively correlated with NT-proBNP and left ventricular mass.
Synapse has enriched 10 related papers. Consider them for comparative context: